Attachment 2b - 60 day FRN

16791

Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
No. of
responses/
respondent

Avg. burden/
response in
hours

Type of respondent

Survey instruments

No. of
respondents

Teacher ..................................

Teacher Survey (Attachment B35) .........................................

4154 ...............

1

10/60

Total ................................

.................................................................................................

961 children ...
892 parents ....
4154 teachers

........................

........................

Dated: March 30, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–6339 Filed 4–4–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–07–07AU]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.

ongoing MRSA prevention efforts at
hospitals reporting to CDC surveillance
systems is unknown. CDC has
developed a survey to assess MRSA
prevention programs in place at health
care facilities reporting MRSA infection
data to CDC through established
surveillance systems. In this project,
infection control practitioners in all 220
hospitals that participate in the MRSA
portion of the Active Bacterial Core
Surveillance System will surveyed
electronically three times. There will be
an initial baseline survey and then two
follow-up surveys, each a year apart.
The surveys will determine if changes
in infection control practice correlate
with changes in rates of MRSA
infections. The proposed survey will
provide data that can be used to assess
progress toward achieving CDC’s Health
Protection Goals. The survey will also
provide data on facility-based MRSA
prevention policies and procedures that
may affect MRSA infection rates. These
results will inform CDC in the
prevention and control of MRSA.
This proposed project supports CDC’s
Goal of ‘‘Healthy People in Healthy
Places’’ and its Strategic Goal to
‘‘Increase the number of health care
institutions that comply with evidence
based guidelines for infection control.’’
There is no cost to respondents other
than their time to complete the survey.

Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Survey to Assess Methicillin-Resistant
Staphylococcus aureus (MRSA)
Prevention Programs among Hospitals
Participating in CDC MRSA
Surveillance Programs—New—National
Center for Preparedness, Detection, and
Control of Infectious Diseases
(NCPDCID) (proposed), Centers for
Disease Control and Prevention.
Background and Brief Description
In October, 2006, CDC recommended
specific strategies to reduce
transmission of multi-drug resistant
organisms, including MRSA, in U.S.
hospitals. Currently detailed data on

ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents

jlentini on PROD1PC65 with NOTICES

Respondents

Number of
responses per
respondent

Average
burden
per response
(in hours)

Total burden
(in hours)

Hospital Infection Control Professionals ..........................................................

220

1

15/60

55

Total ..........................................................................................................

........................

........................

........................

55

VerDate Aug<31>2005

17:37 Apr 04, 2007

Jkt 211001

PO 00000

Frm 00030

Fmt 4703

Sfmt 4703

E:\FR\FM\05APN1.SGM

05APN1

16792

Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices

Dated: March 30, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–6340 Filed 4–4–07; 8:45 am]
BILLING CODE 4163–18–P

this research will give scientists and
health professionals greater insight into
the airborne transmission of disease and
allow them to better assess the potential
effectiveness of preventive measures.
The first part of this study will
measure the quantity and size
distribution of aerosol produced during
human coughs. To accomplish this,
volunteers will cough into a spirometer,
which is a commonly used piston-like
medical device that measures the
volume of air exhaled by a patient. After
the volunteer coughs into the
spirometer, the air in the spirometer
will be drawn into a commercial aerosol
measurement device. These experiments
will also provide information on how
much cough aerosols vary over time for
individuals and how much aerosol
generation varies between individuals.
The second part of this study will
determine how effectively surgical
masks and N95 respirators block coughgenerated aerosols. N95 respirators are
dust masks that are certified to filter out
at least 95% of airborne material during
normal breathing. N95 respirators are
known to be more effective than surgical
masks at filtering out airborne particles
during inhalation, but it is not known
whether masks or respirators are more
effective at blocking cough-generated
aerosols. For this work, masks and
respirators will be placed in a special
holder with a disposable mouthpiece,
and human subjects will cough into the
mouthpiece and through the mask. The
aerosol produced by each subject will be
analyzed before and after flowing
through the mask. These experiments
will determine how effective each mask
or respirator is at preventing the release
of cough-generated aerosols.
Volunteers from part 1 may also
participate in part 2 if they wish. There
will be no costs to study participants
other than their time.

on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project

Centers for Disease Control and
Prevention

Aerosol Generation by Cough—
NEW—The National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).

[60 Day–07–06AP]

Background and Brief Description

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–4766 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information

The Federal Occupational Safety and
Health Act of 1970, section 501, enables
NIOSH to carry out research relevant to
the health and safety of workers. NIOSH
is conducting a two-year study of
airborne clouds of particles or droplets
called ‘‘aerosols’’. Some diseases like
influenza and Severe Acute Respiratory
Syndrome (SARS) can be spread when
people produce infectious aerosols by
coughing or sneezing. Aerosol
transmission of infectious diseases is
especially important to health-care
workers and emergency responders,
who face a much greater risk of
exposure to these hazards than does the
general public. Cough-generated
aerosols are of particular concern
because coughing is one of the most
common symptoms of respiratory
infections. However, substantial gaps
exist in our understanding about the
generation of aerosols during coughing.
This lack of information hampers the
ability of health scientists to model and
predict the generation of infectious
aerosols by coughing and to understand
whether or not cough-generated aerosols
are likely to be an important means of
transmission of particular diseases.
The purpose of this study is to gain
a better understanding of the production
of aerosols by coughing. The results of

ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents

jlentini on PROD1PC65 with NOTICES

Respondents

Number of
responses per
respondent

Average
burden
per response
(in hours)

Total burden
(in hours)

Part 1 participants ............................................................................................
Part 2 participants ............................................................................................

20
120

5
1

1.5
1.5

150
180

Total ..........................................................................................................

........................

........................

........................

330

VerDate Aug<31>2005

17:37 Apr 04, 2007

Jkt 211001

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

E:\FR\FM\05APN1.SGM

05APN1